129 related articles for article (PubMed ID: 18802952)
41. Post cardiac transplantation lymphoproliferative disorder presenting as t(8;14) Burkitt leukaemia/lymphoma treated with low intensity chemotherapy and rituximab.
Windebank K; Walwyn T; Kirk R; Parry G; Hasan A; Bown N; Wilkins B
Pediatr Blood Cancer; 2009 Sep; 53(3):392-6. PubMed ID: 19459198
[TBL] [Abstract][Full Text] [Related]
42. Early-onset versus late-onset HIV-related secondary mania in Uganda.
Nakimuli-Mpungu E; Musisi S; Kiwuwa Mpungu S; Katabira E
Psychosomatics; 2008; 49(6):530-4. PubMed ID: 19122130
[TBL] [Abstract][Full Text] [Related]
43. Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04.
Walenda C; Kouakoussui A; Rouet F; Wemin L; Anaky MF; Msellati P
J Trop Pediatr; 2009 Jun; 55(3):170-6. PubMed ID: 19066169
[TBL] [Abstract][Full Text] [Related]
44. Disease progression in HIV-1 infected children and adolescents--results of a German-Austrian cohort study.
Funk MB; Buchholz B; Notheis G; Neubert J; Feiterna-Sperling C; Ganschow R; Simon T; Hornemann F; Peters AM; Rütschle H; Horneff G; Lechner E; Hanschmann KM; Wintergerst U;
Eur J Med Res; 2008 Aug; 13(8):371-8. PubMed ID: 18952519
[TBL] [Abstract][Full Text] [Related]
45. [Highly active antiretroviral therapy in HIV sero-positive children. Disease progression by baseline clinical, immunological and virological status].
Rodríguez de Schiavi MS; Scrigni A; García Arrigoni P; Bologna R; Barboni G; Redondo J; Nastri M; Mecikovsky D; Cantisano C; Moreno R; Siciliani D; Lencina M; Luedicke N; Rezzónico G; Torolla JL; López Papucci S; Luis M; Libonati C; Gamba L; Barbarysky J; Pérez Hernández E; Zlatkes R
Arch Argent Pediatr; 2009 Jun; 107(3):212-20. PubMed ID: 19543629
[TBL] [Abstract][Full Text] [Related]
46. Novel insights into the early histopathogenesis of immunodeficiency-associated Burkitt lymphoma: a case report of Burkitt microlymphoma arising within HIV lymphadenitis.
Park D; Ozkaya N; Hariharan A
Histopathology; 2016 Sep; 69(3):516-21. PubMed ID: 26953628
[TBL] [Abstract][Full Text] [Related]
47. Prognostic Impact of MUM1/IRF4 Expression in Burkitt Lymphoma (BL): A Reappraisal of 88 BL Patients in Japan.
Satou A; Asano N; Kato S; Elsayed AA; Nakamura N; Miyoshi H; Ohshima K; Nakamura S
Am J Surg Pathol; 2017 Mar; 41(3):389-395. PubMed ID: 28079574
[TBL] [Abstract][Full Text] [Related]
48. Patient compliance in the treatment of Burkitt's lymphoma in rural Zambia: a retrospective study on 80 Burkitt's lymphoma patients in Katete, Zambia.
De Boer JD; Boellaard TN; Parkinson S; Blanchard E; Heij HA
Afr J Paediatr Surg; 2009; 6(1):3-6. PubMed ID: 19661656
[TBL] [Abstract][Full Text] [Related]
49. HIV infection and persistent diarrhoea: a comparative study of HIV positive and HIV negative children.
Nte AR; Eneh AU
Afr J Med Med Sci; 2008 Jun; 37(2):149-55. PubMed ID: 18939398
[TBL] [Abstract][Full Text] [Related]
50. HIV-associated Burkitt lymphoma in a Japanese patient with early submandibular swelling.
Komatsu N; Kawase-Koga Y; Mori Y; Kamikubo Y; Kurokawa M; Takato T
BMC Res Notes; 2013 Dec; 6():557. PubMed ID: 24370065
[TBL] [Abstract][Full Text] [Related]
51. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK
Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110
[TBL] [Abstract][Full Text] [Related]
52. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
53. Phaeohyphomycosis in a tertiary care cancer center.
Ben-Ami R; Lewis RE; Raad II; Kontoyiannis DP
Clin Infect Dis; 2009 Apr; 48(8):1033-41. PubMed ID: 19267655
[TBL] [Abstract][Full Text] [Related]
54. Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited.
Ogwang MD; Bhatia K; Biggar RJ; Mbulaiteye SM
Int J Cancer; 2008 Dec; 123(11):2658-63. PubMed ID: 18767045
[TBL] [Abstract][Full Text] [Related]
55. Endemic Burkitt Lymphoma: Long-term Outcome in 87 Patients Who Presented With Paraplegia in Cameroon.
Hesseling PB; Mbah G; Kouya F; Kimbi C; Nfor P; Kaah J; Kuruvilla R; Best A; Wharin P
Pediatr Hematol Oncol; 2015; 32(8):525-8. PubMed ID: 26606160
[TBL] [Abstract][Full Text] [Related]
56. Stable Incidence and Poor Survival for HIV-Related Burkitt Lymphoma Among the US Veteran Population During the Antiretroviral Era.
Clark E; Royse KE; Dong Y; Chang E; Raychaudhury S; Kramer J; White DL; Chiao E
J Acquir Immune Defic Syndr; 2020 May; 84(1):18-25. PubMed ID: 32251095
[TBL] [Abstract][Full Text] [Related]
57. Current investigations and treatment of Burkitt's lymphoma in Africa.
Orem J; Mbidde EK; Weiderpass E
Trop Doct; 2008 Jan; 38(1):7-11. PubMed ID: 18302850
[TBL] [Abstract][Full Text] [Related]
58. Autopsy diagnosis of endemic burkitt lymphoma as the primary etiology of acute renal failure in children.
Olowu WA; Adelusola KA; Badmos KB; Aina OJ
Pediatr Hematol Oncol; 2005 Jun; 22(4):315-21. PubMed ID: 16020119
[TBL] [Abstract][Full Text] [Related]
59. Destitution, treatment adherence and survival of children with Burkitt lymphoma in a twinning programme in Northwest Cameroon.
Afungchwi GM; Hesseling P; van Elsland SL; Kouya F; Kruger M
Pediatr Blood Cancer; 2019 Dec; 66(12):e27946. PubMed ID: 31436364
[TBL] [Abstract][Full Text] [Related]
60. Epidemiology of adult and pediatric Burkitt lymphoma in Canada: sequelae of the HIV epidemic.
Roy SF; Ghazawi FM; Le M; Lagacé F; Roy CF; Rahme E; Savin E; Zubarev A; Sasseville D; Popradi G; Litvinov IV
Curr Oncol; 2020 Apr; 27(2):83-89. PubMed ID: 32489250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
